1. Home
  2. Live Updates
  3. Erck kgaa

Live Breaking News & Updates on Erck kgaa

Stay informed with the latest breaking news from Erck kgaa on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Erck kgaa and stay connected to the pulse of your community

BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

BioMed X announces the extension of its collaboration with Merck in the research project RNA Splicing in Cancer. Merck has decided to acquire the IP rights in the project results and to continue the project for another year. The goal of the extension is to further validate novel potential drug targets based on these results.

Germany , Heidelberg , Baden-wüberg , German , Alexandra-duarte , Bettina-rohmann-lawrenz , Christian-tidona , Merck-kga , Alexandra-duarte-to-group-leader , Merck-kgaa , Group-leader , University-of-heidelberg

Investegate |Merck KGaA Announcements | Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Investegate announcements from Merck KGaA, Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,

Merck Foundation Announced Winners of Best African Women Researchers and Young African Researchers Awards of Merck Foundation Africa Research Summit– (MARS Awards) 2021

Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the Merck Foundation Africa Research Summit – MARS 2021 Awards ceremony, in partnership with the African Union, through videoconference to felicitate the 13 winners from 8 African countries, for their valuable research work and contribution to empowering women and youth in STEM.

Burkina-faso , Kenya , Nigeria , India , Zimbabwe , Congo , Cameroon , Njua , Cross-river , Makerere , Kampala , Uganda

Investegate |Merck KGaA Announcements | Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Investegate announcements from Merck KGaA, Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,

Investegate |Merck KGaA Announcements | Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Investegate announcements from Merck KGaA, Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,

Bioprocess Validation Market to Eyewitness Massive Growth by 2026 | Merck KGaA, SGS, Eurofins Scientific

Bioprocess Validation Market to Eyewitness Massive Growth by 2026 | Merck KGaA, SGS, Eurofins Scientific

Australia , Japan , United-states , United-kingdom , Argentina , Brazil , China , South-africa , Colombia , United-arab-emirates , Canada , Germany

Bioprocess Validation Market to Eyewitness Massive Growth by 2026 | Merck KGaA, SGS, Eurofins Scientific

Bioprocess Validation Market to Eyewitness Massive Growth by 2026 | Merck KGaA, SGS, Eurofins Scientific

Australia , Japan , United-states , United-kingdom , Argentina , Brazil , China , South-africa , Colombia , United-arab-emirates , Canada , Germany

Investegate |Merck KGaA Announcements | Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Investegate announcements from Merck KGaA, Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,

Investegate |Merck KGaA Announcements | Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Investegate announcements from Merck KGaA, Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,

Merck KGgA venture arm bets on 'next generation' cancer therapeutics player

M Ventures, the strategic, corporate venture capital arm of Merck KGgA, continues to fund iOmx Therapeutics AG, a company developing cancer therapeutics based on next generation immune checkpoint targets.

Germany , Wellington , New-zealand-general- , New-zealand , German , Philipp-beckhove , Nisit-khandelwal , German-cancer-research-centre , Athos-service-gmb , Athos-service-gmbh , Besidesm-ventures , Wellington-partners